Total Payments
$68,314
2024 Payments
$375.68
Companies
18
Transactions
58
Medicare Patients
2,889
Medicare Billing
$264,479
Payment Breakdown by Category
Other$42,772 (62.6%)
Consulting$23,194 (34.0%)
Food & Beverage$1,630 (2.4%)
Travel$718.55 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,772 | 6 | 62.6% |
| Consulting Fee | $23,194 | 8 | 34.0% |
| Food and Beverage | $1,630 | 43 | 2.4% |
| Travel and Lodging | $718.55 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumenis, Inc | $41,842 | 5 | $0 (2021) |
| Solta Medical, a division of Bausch Health US, LLC | $18,452 | 10 | $0 (2024) |
| Allergan, Inc. | $3,973 | 6 | $0 (2020) |
| LUMENIS (AUSTRALIA) PTY. LTD. | $2,000 | 1 | $0 (2020) |
| Lumenis BE ANZ Pty Ltd | $929.66 | 1 | $0 (2022) |
| Galderma Laboratories, L.P. | $249.75 | 10 | $0 (2024) |
| ABBVIE INC. | $204.81 | 2 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $154.02 | 4 | $0 (2020) |
| Johnson & Johnson Health Care Systems Inc. | $112.50 | 1 | $0 (2018) |
| PFIZER INC. | $90.02 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $375.68 | 12 | ABBVIE INC. ($150.00) |
| 2023 | $46.29 | 2 | GENZYME CORPORATION ($23.64) |
| 2022 | $1,068 | 4 | Lumenis BE ANZ Pty Ltd ($929.66) |
| 2021 | $4,637 | 3 | Solta Medical, a division of Bausch Health US, LLC ($2,610) |
| 2020 | $13,406 | 8 | Solta Medical, a division of Bausch Health US, LLC ($6,800) |
| 2019 | $16,257 | 15 | Solta Medical, a division of Bausch Health US, LLC ($8,976) |
| 2018 | $17,686 | 5 | Lumenis, Inc ($17,535) |
| 2017 | $14,837 | 9 | Lumenis, Inc ($12,206) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $11.87 | General |
| Category: DERMATOLOGY | ||||||
| 07/03/2024 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $20.63 | General |
| 06/04/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 03/29/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| 03/28/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: DERMATOLOGY | ||||||
| 03/19/2024 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $26.98 | General |
| 03/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Immunology | ||||||
| 02/22/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 02/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Immunology | ||||||
| 01/16/2024 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $22.46 | General |
| 12/05/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Immunology | ||||||
| 08/30/2023 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $22.65 | General |
| 05/09/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $54.81 | General |
| 04/20/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: Dermatology | ||||||
| 04/06/2022 | Lumenis BE ANZ Pty Ltd | m22 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $929.66 | General |
| Category: Device | ||||||
| 01/24/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $62.15 | General |
| 11/23/2021 | Solta Medical, a division of Bausch Health US, LLC | — | Consulting Fee | Cash or cash equivalent | $2,610.00 | General |
| 05/18/2021 | Lumenis, Inc | Lumenis Pulse 120H (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Urology/Pelvic Health | ||||||
| 01/19/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: DERMATOLOGY | ||||||
| 09/02/2020 | Apyx Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $8.62 | General |
| 08/28/2020 | Allergan, Inc. | BOTOX COSMETIC | Consulting Fee | Cash or cash equivalent | $1,380.00 | General |
| 08/28/2020 | Allergan, Inc. | BOTOX COSMETIC | Consulting Fee | Cash or cash equivalent | $78.58 | General |
| 05/19/2020 | LUMENIS (AUSTRALIA) PTY. LTD. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 705 | 914 | $303,021 | $66,883 |
| 2022 | 11 | 685 | 886 | $286,039 | $61,237 |
| 2021 | 12 | 744 | 1,010 | $308,981 | $69,320 |
| 2020 | 11 | 755 | 1,107 | $294,965 | $67,039 |
Total Patients
2,889
Total Services
3,917
Medicare Billing
$264,479
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 166 | 223 | $102,098 | $20,939 | 20.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 197 | 265 | $41,308 | $11,343 | 27.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 56 | 79 | $42,075 | $8,123 | 19.3% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 26 | 26 | $35,081 | $7,827 | 22.3% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 28 | 28 | $23,300 | $5,976 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 59 | $14,659 | $4,271 | 29.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 65 | 65 | $13,044 | $3,609 | 27.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 45 | 50 | $13,297 | $1,948 | 14.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,968 | $1,171 | 29.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 21 | 41 | $9,226 | $1,036 | 11.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 11 | 11 | $4,555 | $595.95 | 13.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 54 | $409.86 | $44.12 | 10.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 157 | 201 | $91,873 | $18,270 | 19.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 223 | 283 | $44,028 | $11,616 | 26.4% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 59 | 82 | $43,618 | $9,056 | 20.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 20 | 27 | $36,430 | $7,769 | 21.3% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2022 | 19 | 25 | $20,745 | $5,122 | 24.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 62 | 62 | $12,430 | $3,354 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 29 | $7,205 | $2,093 | 29.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 47 | 50 | $13,244 | $1,911 | 14.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 29 | 49 | $10,994 | $1,220 | 11.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 12 | 12 | $4,970 | $772.65 | 15.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 29 | 66 | $500.94 | $52.43 | 10.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 157 | 216 | $97,364 | $21,072 | 21.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 258 | 356 | $54,559 | $15,347 | 28.1% |
About Dr. Edward Ross, MD
Dr. Edward Ross, MD is a Dermatology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740252493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Ross, MD has received a total of $68,314 in payments from pharmaceutical and medical device companies, with $375.68 received in 2024. These payments were reported across 58 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,772).
As a Medicare-enrolled provider, Ross has provided services to 2,889 Medicare beneficiaries, totaling 3,917 services with total Medicare billing of $264,479. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location San Diego, CA
- Active Since 02/06/2006
- Last Updated 08/16/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1740252493
Products in Payments
- Lumenis Pulse 120H (Device) $2,000
- m22 (Device) $929.66
- ALTRENO (Drug) $132.24
- RHOFADE (Drug) $122.69
- XARELTO (Drug) $112.50
- EUCRISA (Drug) $90.02
- DUPIXENT (Biological) $63.69
- COSENTYX (Biological) $50.45
- AMELUZ (Drug) $43.91
- DAXXIFY (Drug) $30.82
- TREMFYA (Drug) $25.00
- TALTZ (Drug) $23.33
- DERMATITIS - DISEASE (Drug) $22.73
- JUBLIA (Drug) $21.78
- OPZELURA (Drug) $21.74
- Ameluz (Drug) $16.42
- DYSPORT (Biological) $15.83
- SOOLANTRA (Drug) $15.81
- EPIDUO FORTE (Drug) $12.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Diego
Dr. Sabrina Fabi, M.d, M.D
Dermatology — Payments: $3.3M
Dermatology $3.3M
Neal Bhatia, Md, MD
Dermatology — Payments: $2.6M
Dermatology $2.6M
Dr. Arisa Ortiz, M.d, M.D
Dermatology — Payments: $354,946
Dermatology $354,946
Dr. Dawn Eichenfield, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $179,796
Dermatology $179,796
Michael Bradshaw, M.d, M.D
Dermatology — Payments: $174,743
Dermatology $174,743
Dr. Tissa Hata, M.d, M.D
Dermatology — Payments: $138,047
Dermatology $138,047